Secondcell Bio to Chair UAE BioTech Symposium in Masdar City, Abu Dhabi
The UAE BioTech Symposium, chaired by Secondcell Bio, will take place on November 6-8, 2024 in Masdar City, Abu Dhabi. The event, organized in partnership with AmCham Abu Dhabi's BioTech Committee and Masdar City, aims to attract U.S. and international BioTech owners and executives to explore opportunities in the UAE's growing BioTech sector. The symposium will feature:
- Approximately 150 qualified attendees
- Discussions on BioTech sector growth, Emirati genomic research, and the future of medicine in the UAE
- Networking opportunities and lab tours
- Information from UAE government entities on business incentives
The inaugural event will be followed by quarterly symposiums across the Middle East, fostering collaboration and innovation in the BioTech industry.
Il Simposio BioTech degli Emirati Arabi Uniti, presieduto da Secondcell Bio, si terrà dal 6 all'8 novembre 2024 a Masdar City, Abu Dhabi. L'evento, organizzato in collaborazione con il Comitato BioTech di AmCham Abu Dhabi e Masdar City, mira ad attrarre proprietari ed esecutivi BioTech statunitensi e internazionali per esplorare opportunità nel crescente settore BioTech degli EAU. Il simposio presenterà:
- Circa 150 partecipanti qualificati
- Discussioni sulla crescita del settore BioTech, sulla ricerca genomica emiratina e sul futuro della medicina negli EAU
- Opportunità di networking e visite ai laboratori
- Informazioni dalle entità governative degli EAU sugli incentivi per le imprese
L'evento inaugurale sarà seguito da simposi trimestrali in tutto il Medio Oriente, promuovendo collaborazione e innovazione nell'industria BioTech.
El Símbposium BioTech de los EAU, presidido por Secondcell Bio, se llevará a cabo del 6 al 8 de noviembre de 2024 en Masdar City, Abu Dabi. El evento, organizado en asociación con el Comité BioTech de AmCham Abu Dabi y Masdar City, busca atraer a propietarios y ejecutivos de BioTech de EE. UU. e internacionales para explorar oportunidades en el creciente sector BioTech de los EAU. El simposio contará con:
- Alrededor de 150 asistentes calificados
- Discusiones sobre el crecimiento del sector BioTech, la investigación genómica emiratí y el futuro de la medicina en los EAU
- Oportunidades de networking y visitas a laboratorios
- Información de entidades gubernamentales de los EAU sobre incentivos empresariales
El evento inaugural será seguido por simposios trimestrales en todo el Medio Oriente, fomentando la colaboración y la innovación en la industria BioTech.
제 아랍에미리트 바이오테크 심포지엄은 Secondcell Bio가 주관하며, 2024년 11월 6일부터 8일까지 아부다비의 마스다르 시티에서 개최됩니다. 이번 행사에서는 AmCham 아부다비 바이오테크 위원회 및 마스다르 시티와 협력하여 미국 및 국제 바이오테크 소유자 및 경영진을 유치하여 아랍에미리트의 성장하는 바이오테크 분야에서 기회를 탐색하는 것을 목표로 하고 있습니다. 심포지엄에서는 다음과 같은 내용이 다루어질 것입니다:
- 약 150명의 자격을 갖춘 참석자
- 바이오테크 분야의 성장, 에미리트의 유전자 연구 및 아랍에미리트의 의학의 미래에 대한 토론
- 네트워킹 기회 및 연구소 투어
- 사업 인센티브에 대한 아랍에미리트 정부 기관의 정보
초청 행사 후에는 중동 전역에서 분기별 심포지엄이 개최되어 바이오테크 산업의 협력과 혁신을 촉진할 것입니다.
Le Symposium BioTech des ÉAU, présidé par Secondcell Bio, se déroulera du 6 au 8 novembre 2024 à Masdar City, Abou Dabi. Cet événement, organisé en collaboration avec le Comité BioTech de l'AmCham Abou Dabi et Masdar City, vise à attirer des propriétaires et des dirigeants de BioTech américains et internationaux pour explorer les opportunités dans le secteur BioTech en pleine expansion des ÉAU. Le symposium comportera :
- Environ 150 participants qualifiés
- Des discussions sur la croissance du secteur BioTech, la recherche génomique émiratie et l'avenir de la médecine aux ÉAU
- Des opportunités de réseautage et des visites de laboratoires
- Des informations fournies par des entités gouvernementales des ÉAU sur les incitations pour les entreprises
L'événement inaugural sera suivi de symposiums trimestriels à travers le Moyen-Orient, favorisant la collaboration et l'innovation dans l'industrie BioTech.
Das BioTech-Symposium der VAE, geleitet von Secondcell Bio, findet vom 6. bis 8. November 2024 in Masdar City, Abu Dhabi, statt. Die Veranstaltung, die in Partnerschaft mit dem BioTech-Ausschuss der AmCham Abu Dhabi und Masdar City organisiert wird, zielt darauf ab, US-amerikanische und internationale BioTech-Besitzer und Führungskräfte anzuziehen, um Möglichkeiten im wachsenden BioTech-Sektor der VAE zu erkunden. Das Symposium wird folgende Themen behandeln:
- Ungefähr 150 qualifizierte Teilnehmer
- Diskussionen über das Wachstum des BioTech-Sektors, emiratische Genomforschung und die Zukunft der Medizin in den VAE
- Netzwerkmöglichkeiten und Laborführungen
- Informationen von staatlichen Stellen der VAE zu Unternehmensanreizen
Die Eröffnungsveranstaltung wird von vierteljährlichen Symposien im gesamten Nahen Osten gefolgt, die Zusammenarbeit und Innovation in der BioTech-Industrie fördern.
- Potential for growth and investment in the UAE's BioTech sector
- Collaboration opportunities with international BioTech companies
- Support from UAE government entities for business expansion
- Networking platform for BioTech sector leaders
- None.
- The
UAE BioTech Symposium will be hosted in partnership with AmCham Abu Dhabi's BioTech Committee and Masdar City - The
UAE BioTech Symposium will attractU.S. and international BioTech owners and executives exploring opportunities in the rapidly growing BioTech sector inAbu Dhabi - The inaugural symposium will be followed by quarterly events with Roadshow destinations across the
Middle East
Further details regarding the symposium and registration information may be found at https://www.uaebiotechsymposium.com.
The exclusive event focusing on advancing the biotechnology sector in
"
The symposium will be held at Masdar City, a pioneering sustainable urban community and world-class business and technology hub that has cultivated a thriving ecosystem of leading global organizations dedicated to evolving research and innovation:
As the leading Life Sciences cluster hub in
In close collaboration with key government entities such as the Department of Health (DOH), the Abu Dhabi Investment Office (ADIO), and the Abu Dhabi Department of Economic Development (ADDED), we are fully aligned with
AmCham Abu Dhabi CEO, Liz Beneski will provide opening remarks for the symposium, which is the first forum of its kind in the region. The symposium will provide attendees the opportunity to hear from distinguished international experts as well as founding members of the AmCham Abu Dhabi BioTech Committee. Key discussion topics will include growth of the BioTech sector across various regions, Emirati genomic research initiatives and the future of medicine in the
Networking opportunities will be available for BioTech sector leaders to gather, discuss and explore potential areas of collaboration along with exclusive immersive visits to local laboratories and research hospitals in
"It has been a privilege working alongside Dr. Shekdar where his expertise and genuine altruistic dedication to advancing science for the benefit of all humanity have been invaluable in inspiring our team to advance our organizational objectives," says Fabienne Duchini of Secondcell Bio, "Under Dr. Shekdar's visionary leadership, the symposium will offer novel insights and a compelling vision for the future of BioTech. I hope you will join us to see all of what the
Several
The symposium will offer an optional weekend program featuring a variety of cultural, leisure and lifestyle experiences in
We are grateful for the support of our generous corporate sponsors and exhibitors. Sponsors include Halia Therapeutics and Innova Therapeutics. International knowledge partners and corporate exhibitors include Jones Lang LaSalle Inc. (JLL), AtkinsRéalis, GRÜNECKER Patent Attorneys and Attorneys-at-Law, Sartorius Stedim Biotech GmbH, BioTech Clusters and university technology transfer offices [LIST-IN-FORMATION].
PRESS BRIEFINGS
We invite members of the press to learn more. Private one-on-one briefings are available for scheduling as follows:
1) Members of
2) Business & technology press: 7am to 5pm, Tuesday October 8, 2024, EST Time Zone
3) All members of the press: 10am to 10pm, Wednesday October 9, 2024, GCC Time Zone
To schedule a private one-on-one press briefing, please contact Fabienne Duchini at
fabienne.duchini@secondcellbio.com.
At a closed-door press briefing, Dr. Shekdar will share his personal experience navigating business opportunities in the
Additional information for members of the press is available here:
About
Arabic site for scientific program: http://www.uaebiotechsymposium.ae
English site for scientific program: https://www.uaebiotechsymposium.com
About AmCham Abu Dhabi
AmCham Abu Dhabi (the trademark of the American Business Group of
About Masdar City
Masdar City is a pioneering sustainable urban community, a world-class business and technology hub, and a "green-print" for cities that want to be part of the solution to climate change. With one of the largest clusters of LEED Platinum buildings in the world, we are dedicated to creating a new kind of city, a new way of working and living, and a more sustainable future for everyone.
The Masdar City Free Zone is a diverse, innovative, and ambitious group of over 1,000 organizations that benefit from comprehensive business support as well as the city's rich ecosystem. Tenants include the International Renewable Energy Agency (IRENA), the
Masdar City hosts a growing residential community and has piloted two generations of autonomous vehicles. It also manages the Masdar Green REIT, a real estate investment trust dedicated to investing in sustainable real estate assets. Currently the Masdar Green REIT is worth nearly AED 2.9 billion. https://masdarcity.ae/
About AmCham Abu Dhabi BioTech Committee
The AmCham BioTech Committee was formed to establish a BioTech sector in
AMCHAM
About Secondcell Bio
Secondcell Bio™ is building public-private partnerships worldwide to scale-up the demonstrated and largely automated platform biotechnology originating from The Rockefeller University. The company was formed by Dr. Kambiz Shekdar, PhD, inventor of Chromovert® Technology. Secondcell Bio owns Chromovert® Technology. https://www.secondcellbio.com/
About Intelligenix Advanced Diagnostics
Intelligenix Advanced Diagnostics is a biotechnology company currently developing novel diagnostic and therapeutic technology for breast and prostate cancer under the rubrics of personalized and precision medicine. Intelligenix AD is developing cutting-edge, targeted therapeutics and companion diagnostic tests that encompass five critical areas: 1) determining cancer risk, 2) cancer early detection and diagnosing, 3) determining the best course of treatment, 4) molecular-based therapeutics, and 5) monitoring treatment effectiveness. Intelligenix Advanced Diagnostic's technology aims to significantly advance cancer disease management via its impressive patented technology platform, which covers these critical areas for precision medicine and ultimately improves patient outcomes and survival rates. https://intelligenix-adx.com/
About Extend Biosciences
Extend Biosciences Inc. is a clinical stage biotechnology company developing a novel drug delivery platform technology (D-VITylation®) that significantly improves the pharmacokinetic properties of peptides and proteins. The Company's lead D-VITylated drug candidate, EXT608, targets the rare disease Hypoparathyroidism (HPT) characterized by inappropriately low circulating levels of parathyroid hormone (PTH). EXT608 is being developed as a subcutaneously self-administered once-weekly dosing regimen for improved patient compliance and superior efficacy. Phase 2 trials in patients are underway. https://extendbio.com/
About Halia Therapeutics
Halia Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for neuroinflammation, metabolic diseases, and chronic inflammation. Through a unique approach targeting inflammatory pathways, Halia aims to deliver groundbreaking treatments to improve patient outcomes in areas of high unmet medical need. https://haliatx.com/
About Jones Lang LaSalle Inc. (JLL) / JLL MENA / JLL Healthcare and Lifsciences
For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500 company with annual revenue of
JLL MEA. Across the
JLL Healthcare and Lifesciences. JLL's Healthcare and Life Sciences consulting team offers a global network of experts with extensive regional expertise. We provide best-in-class advisory services for companies in these sectors, including feasibility studies, market entry and expansion strategies, technical and commercial due diligence. Our comprehensive consulting services help clients navigate complex challenges in the healthcare and life sciences industries.
AMCHAM
About Innova Therapeutics
Innova Therapeutics is a biopharmaceutical company developing a monoclonal antibody (mAb) platform targeting a novel protein that is highly expressed in both solid and hematological cancers. Innova's platform technology is initially focused on targeting cancers including pediatric osteosarcoma, sarcomas, triple negative breast cancer, multiple myeloma and pancreatic cancer. Current cancer therapies only target either the tumors directly or one component of the tumor microenvironment, while the pathway targeted with our therapy impacts both the tumor and tumor microenvironment simultaneously through a common pathway. In addition, a diagnostic is in development which has the tremendous potential for early cancer detection, as well as a prognostic marker for assessing therapeutic benefit of treatments and assessment of potential reoccurrence of cancer. https://www.innovatherapeutics.com/
About 2xceed Destination Management
2xceed delivers bespoke luxury travel, event planning, and corporate services with a focus on exceptional local expertise in
View original content to download multimedia:https://www.prnewswire.com/news-releases/secondcell-bio-to-chair-uae-biotech-symposium-in-masdar-city-abu-dhabi-302252396.html
SOURCE Secondcell Bio, LLC;
FAQ
When and where will the UAE BioTech Symposium take place?
Who is organizing the UAE BioTech Symposium?
What is the main purpose of the UAE BioTech Symposium?
How many attendees are expected at the UAE BioTech Symposium?
